These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 34360794

  • 21. Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy.
    Hann SH, Kim SY, Kim YL, Jo YW, Kang JS, Park H, Choi SY, Kong YY.
    Elife; 2024 Feb 06; 12():. PubMed ID: 38318851
    [Abstract] [Full Text] [Related]

  • 22. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
    Tsai LK, Tsai MS, Ting CH, Li H.
    J Mol Med (Berl); 2008 Nov 06; 86(11):1243-54. PubMed ID: 18649067
    [Abstract] [Full Text] [Related]

  • 23. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK, Chen CL, Tsai YC, Ting CH, Chien YH, Lee NC, Hwu WL.
    Hum Mol Genet; 2016 Feb 15; 25(4):631-41. PubMed ID: 26647309
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
    Madhavan R, Zhao XT, Ruegg MA, Peng HB.
    Mol Cell Neurosci; 2005 Mar 15; 28(3):403-16. PubMed ID: 15737732
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D, Pyles N, Crawford TO, Swoboda KJ, Patitucci TN, Ebert AD, Sumner CJ, Ko CP, Lorson CL.
    Hum Mol Genet; 2015 Jul 15; 24(14):4094-102. PubMed ID: 25911676
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model.
    Bowerman M, Beauvais A, Anderson CL, Kothary R.
    Hum Mol Genet; 2010 Apr 15; 19(8):1468-78. PubMed ID: 20097679
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ultrastructural characterization of peripheral denervation in a mouse model of Type III spinal muscular atrophy.
    Fulceri F, Biagioni F, Limanaqi F, Busceti CL, Ryskalin L, Lenzi P, Fornai F.
    J Neural Transm (Vienna); 2021 Jun 15; 128(6):771-791. PubMed ID: 33999256
    [Abstract] [Full Text] [Related]

  • 40. Improved therapeutic approach for spinal muscular atrophy via ubiquitination-resistant survival motor neuron variant.
    Rhee J, Kang JS, Jo YW, Yoo K, Kim YL, Hann SH, Kim YE, Kim H, Kim JH, Kong YY.
    J Cachexia Sarcopenia Muscle; 2024 Aug 15; 15(4):1404-1417. PubMed ID: 38650097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.